Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review1

被引:6
|
作者
Hernandez-Vasquez, Akram [1 ]
Chavez-Ecos, Fabian [2 ]
Barrenechea-Pulache, Antonio [3 ]
Comande, Daniel [4 ]
Bendezu-Quispe, Guido [5 ]
机构
[1] Univ San Ignacio Loyola, Ctr Excelencia Invest Econ & Sociales Salud, Vicerrectorado Invest, Lima, Peru
[2] Univ Nacl San Luis Gonzaga, Sociedad Cient Estudiantes Medicina Ica, Ica, Peru
[3] Univ Cient Sur, Lima, Peru
[4] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina
[5] Univ Privada Norbert Wiener, Ctr Invest Epidemiol Salud Global, Lima, Peru
来源
PEERJ | 2021年 / 9卷
关键词
COVID-19; SARS-CoV-2; Indigenous peoples; Epidemiology; Latin America; Caribbean region; Systematic review; PREVALENCE; COVID-19;
D O I
10.7717/peerj.12552
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Latin America and the Caribbean (LAC) has presented some of the highest numbers of cases and deaths due to COVID-19 in the world. Even though indigenous communities represent 8% of the total population in this region, the impact of COVID-19 on this historically vulnerable population has only been briefly explored. Thus, this study aimed to estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC. Methods: A systematic review was conducted utilizing multiple databases (registry PROSPERO: CRD42020207862). Studies published in English, Spanish or Portuguese were selected between December 1st, 2019, and April 14th , 2021. The evaluation of the quality of the study was carried out utilizing the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. A qualitative synthesis of the data analyzed was conducted following the MOOSE and PRISMA declarations. Results: Fifteen studies met the inclusion criteria. Eleven studies were carried out in a Brazilian population, three in a Mexican population, and one in a Colombian population. Four studies reported data about the seroprevalence of SARS-CoV-2 in indigenous populations of Brazil (range: 4.2-81.65%). Twelve studies reported lethality in indigenous people (eight in Brazil, three in Mexico, and one in Colombia). In Brazil, a lethality of 53.30% was described in a hospital setting and between 1.83% and 4.03% in community studies. In Mexico, the lethality of COVID-19 ranged between 16.5% and 19.9%. Meanwhile, in Colombia, a lethality of 3.41% was reported. Most studies were deemed to be of good quality. Conclusions: Despite COVID-19 affecting indigenous populations of LAC, there is limited evidence of the seroprevalence and lethality of the infection by SARS-CoV-2 in this population. Future investigations should ensure standardized methods that allow comparability among studies and ensure the precision of the results obtained.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Mortality in children with cancer and SARS-CoV-2 in Latin America: A systematic review
    Dorantes-Acosta, Elisa
    Avila-Montiel, Diana
    Rojas, Jesus Dominguez
    Parra-Niganez, Patricia
    Velasco-Hidalgo, Liliana
    Arias, Sergio
    Gutierrez-Rivera, Lourdes
    Juarez-Villegas, Luis
    Marquez-Gonzalez, Horacio
    [J]. FRONTIERS IN PEDIATRICS, 2022, 10
  • [2] Occupation and SARS-CoV-2 seroprevalence studies: a systematic review
    Boucher, Emily
    Cao, Christian
    D'Mello, Sean
    Duarte, Nathan
    Donnici, Claire
    Duarte, Natalie
    Bennett, Graham
    SeroTracker Consortium, Anil
    Adisesh, Anil
    Arora, Rahul
    Kodama, David
    Bobrovitz, Niklas
    [J]. BMJ OPEN, 2023, 13 (02):
  • [3] Latin America and the Caribbean SARS-CoV-2 Surveillance: Longitudinal Trend Analysis
    Post, Lori
    Ohiomoba, Ramael O.
    Maras, Ashley
    Watts, Sean J.
    Moss, Charles B.
    Murphy, Robert Leo
    Ison, Michael G.
    Achenbach, Chad J.
    Resnick, Danielle
    Singh, Lauren Nadya
    White, Janine
    Chaudhury, Azraa S.
    Boctor, Michael J.
    Welch, Sarah B.
    Oehmke, James Francis
    [J]. JMIR PUBLIC HEALTH AND SURVEILLANCE, 2021, 7 (04):
  • [4] SARS-CoV-2 in Latin America and the Caribbean: The three intersections for critical thinking in health
    Basile, Gonzalo
    [J]. CIENCIA & SAUDE COLETIVA, 2020, 25 (09): : 3557 - 3562
  • [5] Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis
    Figueiredo, Gerusa Maria
    Tengan, Fatima Mitiko
    Campos, Sergio Roberto
    Luna, Expedito Jose
    [J]. CLINICS, 2023, 78
  • [6] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
    Rostami, Ali
    Sepidarkish, Mahdi
    Leeflang, Mariska M. G.
    Riahi, Seyed Mohammad
    Shiadeh, Malihe Nourollahpour
    Esfandyari, Sahar
    Mokdad, Ali H.
    Hotez, Peter J.
    Gasser, Robin B.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (03) : 331 - 340
  • [7] Dispersion patterns of SARS-CoV-2 variants Gamma, Lambda and Mu in Latin America and the Caribbean
    Graf, Tiago
    Martinez, Alexander A.
    Bello, Gonzalo
    Dellicour, Simon
    Lemey, Philippe
    Colizza, Vittoria
    Mazzoli, Mattia
    Poletto, Chiara
    Cardoso, Vanessa Leiko Oikawa
    da Silva, Alexandre Freitas
    Motta, Fernando Couto
    Resende, Paola Cristina
    Siqueira, Marilda M.
    Franco, Leticia
    Gresh, Lionel
    Gabastou, Jean-Marc
    Rodriguez, Angel
    Vicari, Andrea
    Aldighieri, Sylvain
    Mendez-Rico, Jairo
    Leite, Juliana Almeida
    Baumeister, Elsa
    Campos, Josefina
    Pontoriero, Andrea
    Martin, Indira
    Ferguson, Kirvina
    Johnson, Draven
    Beckles, Songee
    Forde, Kasandra
    Sosa, Aldo
    Melendez, Roberto
    Loayza, Roxana
    Avila, Cinthia
    Fortun Fernandez, Evelin Esther
    Guzman Otazo, Carol Jessica
    de Oliveira Santos, Katia Correa
    Abbud, Adriano
    dos Santos, Mirleide Cordeiro
    Ferreira, Jessylene de Almeida
    Fasce, Rodrigo
    Fernandes, Jorge
    Gomez Rangel, Sergio
    Maria Mercado, Marcela
    Pelaez, Dioselina
    Soto-Garita, Claudio
    Cordero-Laurent, Estela
    Duarte-Martinez, Francisco
    Brenes, Hebleen
    Miguel Sanchez, Isaac
    Imbert, Yvonne
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01) : 1837
  • [8] SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
    Naeimi, Reza
    Sepidarkish, Mahdi
    Mollalo, Abolfazl
    Parsa, Hamid
    Mahjour, Sanaz
    Safarpour, Fatemeh
    Almukhtar, Mustafa
    Mechaal, Amal
    Chemaitelly, Hiam
    Sartip, Behnam
    Marhoommirzabak, Elika
    Ardekani, Ali
    Hotez, Peter J.
    Gasser, Robin B.
    Rostami, Ali
    [J]. ECLINICALMEDICINE, 2023, 56
  • [9] Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
    Bobrovitz, Niklas
    Arora, Rahul Krishan
    Cao, Christian
    Boucher, Emily
    Liu, Michael
    Donnici, Claire
    Yanes-Lane, Mercedes
    Whelan, Mairead
    Perlman-Arrow, Sara
    Chen, Judy
    Rahim, Hannah
    Ilincic, Natasha
    Segal, Mitchell
    Duarte, Nathan
    Van Wyk, Jordan
    Yan, Tingting
    Atmaja, Austin
    Rocco, Simona
    Joseph, Abel
    Penny, Lucas
    Clifton, David A.
    Williamson, Tyler
    Yansouni, Cedric P.
    Evans, Timothy Grant
    Chevrier, Jonathan
    Papenburg, Jesse
    Cheng, Matthew P.
    [J]. PLOS ONE, 2021, 16 (06):
  • [10] Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
    Hajissa, Khalid
    Islam, Md Asiful
    Hassan, Siti Asma
    Zaidah, Abdul Rahman
    Ismail, Nabilah
    Mohamed, Zeehaida
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)